Abstract

A COMPARATIVE STUDY ON THE EFFICACY OF INHALER FORMULATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Mizanur Rahaman*, Nagilla Mounika*, Pyarasani Tulasi*, Shaik Fouzia* and 

.

Abstract

This study I thinks about the viability of endorsed portions of inhalational steroidsin COPD Patients with Fluticasone propionate 100μg two times day to day, Budesonide 200 mg two times every day, Beclomethasone dipropionate 200 μg two times day to day for multi month term. In the current review, the segment attributes of the subjects were gathered. Outof the 60 COPD patients gathered 60% were male and 40% were females. During the review itwas seen that the greater part of the populaces was from the metropolitan region (60%) are impacted when contrasted with provincial region (40%) and this is because of specific disturbing elements like allergens, Residue, air contamination and climatic change. It was seenthat 45% of patients coming to the facility with COPD were between the age bunch 35-65 years old when contrast with other age gatherings. Patients in the age gathering of 46 to 50 areexpanding number in this treatment. Out of 60 patients, 20 (33%) were in treatment with Budesonide Inward breath. Patients showed improvement in COPD with mean worth of18.9%. Out of 60 patients, 20 (33%) were in treatment with Beclomethasone Inward breath. Patients showed improvement in COPD with mean worth of 13.36%. Symptomatic improvement was seen in every one of the three gatherings. The FEV1 improved concerning gauge. It very well may be reasoned that fluticasone propionate is better than budesonide and beclomethasone dipropionate in further developing lung capability, diminishing side effects and need for salvage medicine in COPD. Patient consistence was great with every one of the three medications and there is no antagonistic impact. Every one of the three medications are very much endured at dosages utilized in this review.

Keywords: Inhaler Formulation, Fluticasone Propionate, Budesonide, Beclomethasone Dipropionate, Chronic Obstructive Pulmonary Disease.